Equate Childrens Vaporizing

Description

Equate Children's Vaporizing Rub is a topical formulation designed for pediatric use. It is presented in an ointment dosage form, characterized by its semi-solid consistency. The product is intended to provide soothing relief for children experiencing cough and congestion. The formulation includes a blend of active ingredients that work synergistically to alleviate symptoms associated with colds. The appearance of the rub is typically a translucent or opaque ointment, which may vary in color. The product is specifically formulated to be safe for children, adhering to pediatric guidelines for topical applications.

Uses and Indications

This drug is indicated for the temporary relief of cough due to minor throat and bronchial irritation associated with a cold. Additionally, it is indicated for the temporary relief of minor aches and pains of muscles and joints.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 2 years and older, a thick layer of the product should be applied to the throat and chest to alleviate cough symptoms, or it may be rubbed onto sore, aching muscles and joints. If desired, the treated area may be covered with a warm, dry cloth to enhance the effect. It is recommended that clothing around the throat and chest be left loose to facilitate the release of vapors to the nose and mouth. The product may be used up to three times daily or as directed by a healthcare professional.

For children under 2 years of age, consultation with a healthcare provider is advised prior to use.

Contraindications

Use of this product is contraindicated in the following situations:

Heating, microwaving, or adding the product to hot water or any container where heating water occurs is prohibited, as this may cause splattering and result in burns. The product should not be taken by mouth or placed in the nostrils, as this may lead to adverse effects. Contact with the eyes must be avoided to prevent irritation or injury. Application to wounds or damaged skin is contraindicated due to the risk of exacerbating the condition. Additionally, the product should not be bandaged tightly, as this may lead to complications.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to consult a physician prior to use if they have a cough accompanied by excessive phlegm (mucus) or a chronic cough that persists, particularly in individuals with a history of smoking, asthma, or emphysema.

When utilizing this product, it is imperative to adhere to the following precautions to ensure safety and efficacy:

• The product should not be heated, microwaved, or added to hot water or any container that may involve heating water, as this may lead to splattering and potential burns.

• It is contraindicated to ingest the product or to introduce it into the nostrils.

• Care should be taken to avoid contact with the eyes.

• The product must not be applied to wounds or damaged skin.

• Bandaging should not be done tightly over the application site.

Patients should be instructed to discontinue use and seek medical advice if any of the following occur:

• A cough persists for more than 7 days, recurs, or is accompanied by fever, rash, or a headache that lasts, as these symptoms may indicate a serious underlying condition.

• Muscle aches and pains either worsen, persist beyond 7 days, or resolve only to recur within a few days.

It is essential to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center should be made without delay.

Side Effects

Patients should discontinue use and consult a healthcare professional if they experience a cough that lasts more than 7 days, recurs, or is accompanied by fever, rash, or a persistent headache, as these symptoms may indicate a serious underlying condition.

Additionally, if muscle aches and pains worsen, persist for more than 7 days, or resolve only to return within a few days, patients are advised to seek medical attention. These reactions warrant careful evaluation to rule out any significant health issues.

Drug Interactions

There are no reported drug interactions associated with the use of this medication. Additionally, no interactions with laboratory tests have been identified. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Equate Childrens Vaporizing (camphor, eucalyptus oil, menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should consult a healthcare professional before use. For children aged 2 years and older, the product may be applied as a thick layer on the throat and chest to alleviate cough or on sore, aching muscles and joints. It is recommended to use the product up to three times daily or as directed by a healthcare provider.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical assistance or contact a Poison Control Center without delay.

Prompt action is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action and management strategies.

Healthcare providers should ensure that patients are aware of the importance of timely reporting of any suspected overdosage to facilitate effective treatment and minimize risks.

Nonclinical Toxicology

If pregnant or breast-feeding, it is advised to consult a health professional prior to use. No non-teratogenic effects have been specified in the available data. Additionally, there are no details provided regarding nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed to discontinue use and consult a doctor if they experience a cough that lasts more than 7 days, recurs, or is accompanied by fever, rash, or a persistent headache, as these may indicate a serious condition. Additionally, they should seek medical advice if muscle aches and pains worsen, persist for more than 7 days, or resolve only to return within a few days.

When using this product, patients must be cautioned against heating, microwaving, or adding it to hot water or any container that may heat water, as this could lead to splattering and burns. They should not take the product by mouth or place it in their nostrils, and care should be taken to avoid contact with the eyes. Patients should also refrain from applying the product to wounds or damaged skin and should not bandage the area tightly.

Furthermore, healthcare providers should encourage patients to consult a doctor before use if they have a cough that produces excessive phlegm (mucus) or if they have a chronic cough associated with smoking, asthma, or emphysema.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from excessive heat. Special care should be taken to avoid heating the product; it must not be heated, microwaved, or added to hot water or any container that may involve heating water, as this could lead to splattering and potential burns.

Additionally, it is essential to keep the product out of reach of children. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically and may be used up to three times daily or as directed by a healthcare professional. Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. It is important to keep the product out of reach of children, and in the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Drug Information (PDF)

This file contains official product information for Equate Childrens Vaporizing, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)